US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
  • 111.480
  • -1.620-1.43%
Close Nov 1 16:00 ET
  • 111.480
  • 0.0000.00%
Post 20:02 ET
26.51BMarket Cap-48322P/E (TTM)

BioNTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioNTech Q3 2024 Estimates Date

Currency：EURNov 4, 2024

Estimate YoY
Revenue
516.02M
-42.36%
EPS
-1.70
-354.37%
Analyst Rating
Buy

Oct 31, 2024

BioNTech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.792B--
Nov 4, 20242024/Q3-- / 516.021M--
Aug 5, 20242024/Q2128.700M / 135.687M--
May 6, 20242024/Q1187.600M / 372.284M--
Mar 20, 20242023/Q41.479B / 1.850B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.792B--
Nov 4, 20242024/Q3-- / 516.021M--
Aug 5, 20242024/Q2128.700M / 135.687M--
May 6, 20242024/Q1187.600M / 372.284M--
Mar 20, 20242023/Q41.479B / 1.850B--

Unlock Free Earnings Estimates

BioNTech Earnings Reports

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5 06:37 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5 06:37 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    May 17 16:18 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    May 6 07:23 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Buy

    • Buy

      56.25%

    • Hold

      43.75%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Infectious Disease
    Infectious Disease
    Intraday+0.80%